Anaphylactoid reaction after verteporfin therapy

American Journal of Ophthalmology

Volumn 140, Issue 5, 2005, Pages 936-937

  Doshi, Amish B ^a   Moshfeghi, Darius M ^a,b   Jack, Robert L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; DIPHENHYDRAMINE; FAMOTIDINE; METHYLPREDNISOLONE;

AGED; ANAPHYLAXIS; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; DRUG EXPOSURE; DYSPNEA; EDEMA; FEMALE; FLUORESCENCE ANGIOGRAPHY; FLUSHING; HAND; HUMAN; LARYNX EDEMA; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA DEGENERATION; SIDE EFFECT; THROAT DISEASE; WHEEZING;

AGED, 80 AND OVER; ANAPHYLAXIS; DIPHENHYDRAMINE; DRUG THERAPY, COMBINATION; FAMOTIDINE; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MACULAR DEGENERATION; METHYLPREDNISOLONE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS;

EID: 28444457478     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2005.05.033     Document Type: Article

References (5)

1. Treatment of Age-related Macular Degeneration with Photodynamic Therapy (TAP) Study Group Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin one-year results of 2 randomized clinical trials (TAP report 1) Arch Ophthalmol 117 1999 1329 1345
2. N.M. Bessler Vam Study Writing Committee Verteporfin therapy in age-related macular degeneration (VAM) an open-label multicenter photodynamic therapy study of 4,435 patients Retina 24 2004 512 520
3. A.S. Noffke, L.M. Jampol, D.V. Weinberg, A. Munana A potentially life-threatening adverse reaction to verteporfin Arch Ophthalmol 119 2001 143
4. M.T. Cahill, B.T. Smith, S. Fekrat Adverse reaction characterized by chest pain, shortness of breath, and syncope associated with verteporfin (Visudyne) Am J Opthalmol 134 2002 281 282
5. M.C. Noone, J.D. Osguthorpe Anaphylaxis Otolaryngol Clin North Am 36 2003 1009 1020